Allogene Therapeutics, Inc. (ALLO) earnings
ALLO earnings moved a median of -4.43% by the close. Quarterly and annual ALLO reports and results, each read against the price at its own news timestamp. Back to the ALLO overview →
29 measured ALLO earnings events.
Where these ALLO earnings landedvs 29 measured ALLO earnings reactions
| Middle 50% of ALLO earnings reactions | -7.91% to +1.91% |
|---|---|
| Median reaction (to close) | -4.43% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 ALLO earnings events with a measured close landed between -7.91% and +1.91%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update | Press release | -3.73% | -7.91% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.73% | -7.91% | |
| Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update | Press release | +0.80% | +1.60% | |
| Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update | Press release | +0.00% | -6.96% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.96% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.93% | -6.25% | |
| Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update | Press release | +3.77% | +12.38% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.77% | +12.38% | |
| Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update | Press release | +2.48% | +0.00% | |
| Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update | Press release | +1.94% | +1.91% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.94% | +1.91% | |
| Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update | Press release | +0.00% | -3.64% | |
| Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update | Press release | -0.46% | -13.38% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.46% | -13.38% | |
| Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update | Press release | -0.63% | -18.99% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.43% | |
| Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update | Press release | -5.56% | -4.94% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -5.56% | -4.94% | |
| Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update | Press release | +2.19% | -3.65% | |
| Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update | Press release | -6.92% | -9.23% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.92% | -9.23% | |
| Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update | Press release | -3.00% | -2.00% | |
| Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update | Press release | +7.38% | -8.92% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +7.38% | -8.92% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.74% | +4.72% | |
| Form 10-K/A Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.74% | +4.72% | |
| Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update | Press release | +6.07% | +11.82% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +6.07% | +11.82% | |
| Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023 | Press release | +0.37% | -1.49% |
Keep exploring
More ALLO: analyst actions → · SEC filings → · ALLO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MATEON THERAPEUTICS (MATN) | 318 | 0.00% | 35% |
| Senseonics Holdings, Inc. (SENS) | 318 | -0.44% | 42% |
| Denali Therapeutics Inc. (DNLI) | 316 | +0.07% | 51% |
| Myomo Inc. (MYO) | 315 | +0.35% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.